NRX Pharmaceuticals (NRXP) Short term Debt (2021 - 2025)
NRX Pharmaceuticals (NRXP) posted quarterly Short term Debt of $152000.0 for Q3 2025, down 76.03% year-over-year from $634000.0 in Q3 2024, and down 59.79% quarter-over-quarter from $378000.0 in Q2 2025.
NRX Pharmaceuticals (NRXP) Short term Debt (2021 - 2025) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Short term Debt for 4 consecutive years, with $152000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Short term Debt fell 76.03% year-over-year to $152000.0; the TTM figure through Sep 2025 stood at $152000.0 (down 76.03% YoY), while the FY2024 annual figure was $320000.0, changed N/A from the prior year.
- Short term Debt eased to $152000.0 in Q3 2025 per NRXP's latest filing, from $378000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $26.3 million in Q3 2021 and bottomed at $152000.0 in Q3 2025.
- Historically, Short term Debt has averaged $6.8 million across 4 years, with a median of $943000.0 in 2024.
- On a YoY basis, Short term Debt climbed as much as 59.92% in 2025 and fell as far as 76.03% in 2025.
- NRX Pharmaceuticals' Short term Debt stood at $4.6 million in 2021, then plunged by 45.9% to $2.5 million in 2022, then sank by 87.09% to $320000.0 in 2024, then tumbled by 52.5% to $152000.0 in 2025.
- Business Quant data shows NRXP's Short term Debt at $152000.0 in Q3 2025, $378000.0 in Q2 2025, and $320000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Dec 31, 2024 | 320,000.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 943,000.00 |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Sep 30, 2021 | 26.28 Mn |
| Jun 30, 2021 | 25.87 Mn |